Drugs Made In America Acquisition II Corp. Unit (DMIIU) is a publicly traded company in the Financial Services sector, operating within the Asset Management industry. The company is headquartered in Fort Lauderdale, FL, United States. The current CEO is Roger Bendelac.
DMIIU has IPO date of 2025-09-25, 2 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $633.96M.
No company description available.
